Clareo Health | A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Body mass index between 18 and 30 kg/m\^2, inclusive, at the Screening Visit
Normal ECG at the Screening Visit
Normal renal function at Screening
You may not be if
History of ventricular arrhythmias
History of heart disease or conduction disorders
History of dizziness and/or recurrent headaches (ie, daily headaches lasting for a 1-week duration in the last month prior to study intervention administration)
